These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set. Burke SL; Hu T; Naseh M; Fava NM; O'Driscoll J; Alvarez D; Cottler LB; Duara R Aging Clin Exp Res; 2019 Sep; 31(9):1283-1297. PubMed ID: 30535620 [TBL] [Abstract][Full Text] [Related]
14. Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia. Grilli MD; Wank AA; Bercel JJ; Ryan L J Int Neuropsychol Soc; 2018 Nov; 24(10):1073-1083. PubMed ID: 30136918 [TBL] [Abstract][Full Text] [Related]
15. Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. Dodge HH; Zhu J; Mattek NC; Austin D; Kornfeld J; Kaye JA PLoS One; 2015; 10(9):e0138095. PubMed ID: 26379170 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Petersen RC; Smith GE; Ivnik RJ; Tangalos EG; Schaid DJ; Thibodeau SN; Kokmen E; Waring SC; Kurland LT JAMA; 1995 Apr; 273(16):1274-8. PubMed ID: 7646655 [TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design. Qian J; Hyman BT; Betensky RA JAMA Neurol; 2017 May; 74(5):540-548. PubMed ID: 28288263 [TBL] [Abstract][Full Text] [Related]
20. Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease. Luo J; Weng H; Morris JC; Xiong C J Prev Alzheimers Dis; 2018; 5(2):110-119. PubMed ID: 29616704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]